The Effect of Radiotherapy for Treatment of Head and Neck Cancer on Oral Flora and Saliva

被引:41
|
作者
Arrifin, Azirrawani [1 ]
Heidari, Ellie [2 ]
Burke, Mary [3 ]
Fenlon, Michael R. [4 ]
Banerjee, Avijit [5 ]
机构
[1] Univ Sains Malaysia, Fixed & Removable Prosthodont, Hlth Campus, Kelantan, Malaysia
[2] Kings Coll London, Dent Inst, Sedat & Special Care Dent, Guys Hosp, London, England
[3] Guys & St Thomas Hosp NHS Fdn Trust, Guys Hosp, Special Care Dent, London, England
[4] Kings Coll London, Guys Hosp, Dent Inst, Prosthodont, London, England
[5] Kings Coll London, Guys Hosp, Dent Inst, Cariol & Operat Dent, London, England
关键词
cancer microflora; quality of life; radiotherapy; saliva; xerostomia; RADIATION-INDUCED XEROSTOMIA; CLEARANCE; GLUCOSE;
D O I
10.3290/j.ohpd.a41364
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Purpose: Radiotherapy causes xerostomia in patients treated for head and neck cancer. This study investigated changes in quality and quantity of saliva after radiotherapy and possible associations between these changes and alterations in oral flora. Materials and Methods: The study was a prospective cohort study of patients receiving radiotherapy for head and neck cancer. Suitable patients were recruited before treatment commenced, and informed consent was obtained. Patients were examined, and provided unstimulated and stimulated saliva samples. Quantity of saliva, buffering capacity and pH were measured. Oral flora was cultured from the saliva samples. Oral clearance of glucose and of lactose was measured. These interventions were repeated at intervals after radiotherapy had been completed. Results: Eighteen patients were recruited. Stimulated and unstimulated saliva flow rates, glucose clearance, salivary pH and buffering capacity were significantly reduced after radiotherapy. Candida aibicans counts were significantly increased. These increases were significantly correlated with reductions in stimulated and unstimulated salivary flow rates. Counts of lactobacilli, Streptococcus mutans and Bifidobacteriaceae increased, but not statistically significantly. Conclusions: Therapeutic radiotherapy significantly reduced the quality and quantity of saliva in head and neck cancer patients. These reductions were associated with increased C. albicans counts.
引用
收藏
页码:425 / 429
页数:5
相关论文
共 50 条
  • [31] Individualized pharmacological treatment of oral mucositis pain in patients with head and neck cancer receiving radiotherapy
    Ingrid Stenstrom Ling
    Britt Larsson
    Supportive Care in Cancer, 2011, 19 : 1343 - 1350
  • [32] Saliva 8 hydroxy-2 '-deoxyguanosine changes following radiotherapy in patients with head and neck cancer
    Abassi, F.
    Mirzaii-Dizgah, I
    Manifar, S.
    Kazemian, A.
    Khatami, R.
    Nazari-Sharbayani, F.
    DENTAL CADMOS, 2016, 84 (08) : 514 - 517
  • [33] Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors
    Beetz, Ivo
    Schilstra, Cornelis
    Burlage, Fred R.
    Koken, Phil W.
    Doornaert, Patricia
    Bijl, Henk P.
    Chouvalova, Olga
    Leemans, C. Rene
    de Bock, Geertruida H.
    Christianen, Miranda E. M. C.
    van der Laan, Bernard F. A. M.
    Vissink, Arjan
    Steenbakkers, Roel J. H. M.
    Langendijk, Johannes A.
    RADIOTHERAPY AND ONCOLOGY, 2012, 105 (01) : 86 - 93
  • [34] Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy
    Ourania Nicolatou-Galitis
    Aristea Velegraki
    Anastasia Sotiropoulou-Lontou
    Konstantinos Dardoufas
    Vassilis Kouloulias
    Konstantinos Kyprianou
    Georgia Kolitsi
    Christos Skarleas
    George Pissakas
    Vassilis S. Papanicolaou
    John Kouvaris
    Supportive Care in Cancer, 2006, 14 : 44 - 51
  • [35] Effect of fluconazole antifungal prophylaxis on oral mucositis in head and neck cancer patients receiving radiotherapy
    Nicolatou-Galitis, O
    Velegraki, A
    Sotiropoulou-Lontou, A
    Dardoufas, K
    Kouloulias, V
    Kyprianou, K
    Kolitsi, G
    Skarleas, C
    Pissakas, G
    Papanicolaou, VS
    Kouvaris, J
    SUPPORTIVE CARE IN CANCER, 2006, 14 (01) : 44 - 51
  • [36] Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial
    Stokman, MA
    Spijkervet, FKL
    Burlage, FR
    Dijkstra, PU
    Manson, WL
    de Vries, EGE
    Roodenburg, JLN
    BRITISH JOURNAL OF CANCER, 2003, 88 (07) : 1012 - 1016
  • [37] Prevention and treatment of the consequences of head and neck radiotherapy
    Vissink, A
    Burlage, FR
    Spijkervet, FKL
    Jansma, J
    Coppes, RP
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 2003, 14 (03) : 213 - 225
  • [38] Efficacy of gel-based artificial saliva on Candida colonization and saliva properties in xerostomic post-radiotherapy head and neck cancer patients: a randomized controlled trial
    Lam-ubol, Aroonwan
    Matangkasombut, Oranart
    Trachootham, Dunyaporn
    Tarapan, Supanat
    Sattabanasuk, Vanthana
    Talungchit, Sineepat
    Paemuang, Wannaporn
    Phonyiam, Tawaree
    Chokchaitam, Orapin
    Mungkung, On-ong
    CLINICAL ORAL INVESTIGATIONS, 2021, 25 (04) : 1815 - 1827
  • [39] Cytokines in saliva increase in head and neck cancer patients after treatment
    Russo, Nickole
    Bellile, Emily
    Murdoch-Kinch, Carol Anne
    Liu, Min
    Eisbruch, Avi
    Wolf, Greg T.
    D'Silva, Nisha J.
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2016, 122 (04): : 483 - +
  • [40] Effects of photobiomodulation and bethanechol chloride treatment on salivary composition and flow rate in head and neck cancer patients undergoing radiotherapy: longitudinal interventional experimental clinical study
    Schepanski, Natalia
    Liebl, Bruna Melo da Silva
    Mendes, Reila Taina
    Costa, Floriatan Santos
    Amaral, Clarice D. B.
    Machado, Raquel C.
    Nogueira, Ana Rita A.
    Sassi, Laurindo Moacir
    de Araujo, Melissa Rodrigues
    SUPPORTIVE CARE IN CANCER, 2025, 33 (02)